Vampirinip II

Vampirinip II Brand names, Vampirinip II Analogs

Vampirinip II Brand Names Mixture

No information avaliable

Vampirinip II Chemical_Formula

C₁₉H₁₆O₄

Vampirinip II RX_link

http://www.rxlist.com/cgi/generic/warfarin.htm

Vampirinip II fda sheet

Vampirinip_II FDA

Vampirinip II msds (material safety sheet)

Vampirinip_II MSDS

Vampirinip II Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Vampirinip II Molecular Weight

308.328 g/mol

Vampirinip II Melting Point

161 ^oC

Vampirinip II H₂O Solubility

17 mg/L

Vampirinip II State

Solid

Vampirinip II LogP

3.505

Vampirinip II Dosage Forms

Powder for solution; Tablet

Vampirinip II Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Vampirinip II Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Vampirinip II Absorption

No information avaliable

Vampirinip II side effects and Toxicity

LD₅₀=374 (orally in mice)

Vampirinip II Patient Information